par Bouwhuis, Marna G;Suciu, Stefan
;Collette, Sandra;Aamdal, S;Kruit, Wim H;Bastholt, Lars;Stierner, Ulrika;Sales, François
;Patel, Poulam;Punt, Cornelis;Hernberg, Micaela;Spatz, Alain;ten Hagen, Timo L M;Hansson, Johan;Eggermont, A;EORTC Melanoma Group and the Nordic Melanoma Group,
Référence Journal of the National Cancer Institute, 101, 12, page (869-877)
Publication Publié, 2009-06


Référence Journal of the National Cancer Institute, 101, 12, page (869-877)
Publication Publié, 2009-06
Article révisé par les pairs
Titre: |
|
Auteur: | Bouwhuis, Marna G; Suciu, Stefan; Collette, Sandra; Aamdal, S; Kruit, Wim H; Bastholt, Lars; Stierner, Ulrika; Sales, François; Patel, Poulam; Punt, Cornelis; Hernberg, Micaela; Spatz, Alain; ten Hagen, Timo L M; Hansson, Johan; Eggermont, A; EORTC Melanoma Group and the Nordic Melanoma Group, |
Informations sur la publication: | Journal of the National Cancer Institute, 101, 12, page (869-877) |
Statut de publication: | Publié, 2009-06 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Adjuvants, Immunologic -- administration & dosage -- therapeutic use |
Adult | |
Aged | |
Antibodies, Anticardiolipin -- blood | |
Antibodies, Antinuclear -- blood | |
Autoantibodies -- blood | |
Bias (Epidemiology) | |
Confounding Factors (Epidemiology) | |
Disease-Free Survival | |
Enzyme-Linked Immunosorbent Assay | |
Female | |
Humans | |
Interferon-alpha -- administration & dosage -- therapeutic use | |
Male | |
Melanoma -- drug therapy -- immunology | |
Middle Aged | |
Odds Ratio | |
Proportional Hazards Models | |
Randomized Controlled Trials as Topic | |
Skin Neoplasms -- drug therapy -- immunology | |
Time Factors | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0027-8874 |
info:doi/10.1093/jnci/djp132 | |
info:pii/djp132 | |
info:scp/67449138506 | |
info:pmid/19509353 |